Cipla Intrinsic Value

CIPLA • Healthcare
Current Stock Price
₹1465.70
Primary Intrinsic Value
₹1472.24
Market Cap
₹237.4K Cr
+100.0% Upside
Median Value
₹2931.40
Value Range
₹440 - ₹3664
Assessment
Trading Below Calculated Value
Safety Margin
50.0%

CIPLA Valuation Methods Summary

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹1472.24 ₹1177.79 - ₹1766.69 +0.4% EPS: ₹66.92, Sector P/E: 22x
Book Value Method asset ₹3664.25 ₹3297.83 - ₹4030.68 +150.0% Book Value/Share: ₹1931.42, P/B: 2.0x
Revenue Multiple Method revenue ₹2931.40 ₹2638.26 - ₹3224.54 +100.0% Revenue/Share: ₹1905.19, P/S: 2.0x
EBITDA Multiple Method earnings ₹2931.40 ₹2638.26 - ₹3224.54 +100.0% EBITDA: ₹8088.00Cr, EV/EBITDA: 10x
Simple DCF (5Y) dcf ₹3154.00 ₹2523.20 - ₹3784.80 +115.2% CF Growth: 7.4%, Discount: 15%
PEG Ratio Method growth ₹439.71 ₹395.74 - ₹483.68 -70.0% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹1033.91 ₹930.52 - ₹1137.30 -29.5% Revenue Growth: 6.0%, Adj P/E: 15.5x
ROE Based Valuation profitability ₹2931.40 ₹2638.26 - ₹3224.54 +100.0% ROE: 17.3%, P/E Multiple: 14x
Graham Defensive Method conservative ₹1705.33 ₹1534.80 - ₹1875.86 +16.3% EPS: ₹66.92, BVPS: ₹1931.42
Method Types: Earnings Asset DCF Growth Dividend Conservative

Want to compare with current market value? Check CIPLA share price latest .

Valuation Comparison Chart

CIPLA Intrinsic Value Analysis

What is the intrinsic value of CIPLA?

Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Cipla (CIPLA) is ₹2931.40 (median value). With the current market price of ₹1465.70, this represents a +100.0% variance from our estimated fair value.

The valuation range spans from ₹439.71 to ₹3664.25, indicating ₹439.71 - ₹3664.25.

Is CIPLA undervalued or overvalued?

Based on our multi-method analysis, Cipla (CIPLA) appears to be trading below calculated value by approximately 100.0%.

Financial Health Analysis

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Current Ratio 37.86 Industry Standard: 2.0+ Above 2.0 Measures short-term liquidity capacity
Debt to Equity Ratio 1.19 Industry Standard: <0.5 Above 1.0 Indicates financial leverage level
Return on Equity 17.3% Industry Standard: 15%+ Above 15% Measures shareholder return efficiency
Operating Margin 24.0% Industry Standard: 20%+ Above 20% Indicates operational efficiency level
Asset Turnover Ratio 0.83x Industry Standard: 1.0x+ Above 0.5x Measures asset utilization efficiency

Cash Flow Quality Analysis

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2025 ₹5,005 Cr ₹3,164 Cr Positive Free Cash Flow 8/10
March 2024 ₹4,134 Cr ₹2,643 Cr Positive Free Cash Flow 8/10
March 2023 ₹3,238 Cr ₹2,050 Cr Positive Free Cash Flow 8/10
March 2022 ₹3,326 Cr ₹2,397 Cr Positive Free Cash Flow 8/10
March 2021 ₹3,755 Cr ₹2,568 Cr Positive Free Cash Flow 8/10